Barry & Fitzwilliam profit rises 6% on back of ‘fantastic’ sales of Corona
The company, which claims responsibility for introducing Corona to the Irish market, said the results for 2008 and the financial position at year end were satisfactory. The directors expect continued growth for the foreseeable future, according to accounts just filed.
Company director, Michael Barry said much of this year’s growth is due to the phenomenal sales of Corona. In August, volume sales of Corona surged 50% compared with the same month last year.
